相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens
Chengcheng Zou et al.
JOURNAL OF VIROLOGY (2019)
VACCINOLOGY Structural topology defines protective CD8+ T cell epitopes in the HIV proteome
Gaurav D. Gaiha et al.
SCIENCE (2019)
Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis
Joris Hemelaar et al.
LANCET INFECTIOUS DISEASES (2019)
A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
Felicity Hartnell et al.
FRONTIERS IN IMMUNOLOGY (2019)
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial
Youyi Fong et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Dan H. Barouch et al.
LANCET (2018)
Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1
Nicola J. Borthwick et al.
PLOS ONE (2018)
CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication
Hayato Murakoshi et al.
RETROVIROLOGY (2018)
Novel therapies/hopes for HIV cure in perinatally acquired HIV-positive adolescents
Thomas Joshua Pasvol et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
Carly M. Bliss et al.
SCIENTIFIC REPORTS (2018)
HIV control: Is getting there the same as staying there?
Philip Goulder et al.
PLOS PATHOGENS (2018)
Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?
Lais Teodoro da Silva et al.
FRONTIERS IN IMMUNOLOGY (2018)
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly E. Janes et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects
Gemma Hancock et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2017)
Impact of HLA-DRB1 allele polymorphisms on control of HIV infection in a Peruvian MSM cohort
B. Oriol-Tordera et al.
HLA (2017)
Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines
Nicola Borthwick et al.
PLOS ONE (2017)
Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens
Nathifa Moyo et al.
PLOS ONE (2017)
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition
Peter J. Hayes et al.
AIDS (2016)
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection
Beatrice Ondondo et al.
MOLECULAR THERAPY (2016)
Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E
Scott G. Hansen et al.
SCIENCE (2016)
Control of HIV-1 replication in vitro by vaccine-induced human CDS+ T cells through conserved subdominant Pol epitopes
Tina Ahmed et al.
VACCINE (2016)
A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial
T. Hertz et al.
VACCINE (2016)
Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine
James Theiler et al.
SCIENTIFIC REPORTS (2016)
Which therapeutic strategy will achieve a cure for HIV-1?
Anthony R. Cillo et al.
CURRENT OPINION IN VIROLOGY (2016)
Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults
Gaudensia Mutua et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Paediatric HIV infection: the potential for cure
Philip J. Goulder et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Advancing the HIV cure agenda: the next 5 years
John Thornhill et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2015)
Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point
Zaza M. Ndhlovu et al.
IMMUNITY (2015)
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques
Beatriz Mothe et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes
Hayato Murakoshi et al.
JOURNAL OF VIROLOGY (2015)
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Kai Deng et al.
NATURE (2015)
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
Juliet Mpendo et al.
PLOS ONE (2015)
Very early combination antiretroviral therapy in infants: prospects for cure
Kaitlin Rainwater-Lovett et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Transient IL-10 receptor blockade can enhance CD8+ T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen
Genevieve Clutton et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients
Ling Yue et al.
PLOS PATHOGENS (2015)
Identification of Effective Subdominant Anti-HIV-1 CD8+T Cells Within Entire Post-infection and Post-vaccination Immune Responses
Gemma Hancock et al.
PLOS PATHOGENS (2015)
Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques
Nicola J. Borthwick et al.
IMMUNITY INFLAMMATION AND DISEASE (2015)
Optimizing parallel induction of HIV type 1-specific antibody and T-cell responses by multicomponent subunit vaccines
Genevieve Clutton et al.
AIDS (2014)
Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines
Tomas Hanke
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Impact of HLA Selection Pressure on HIV Fitness at a Population Level in Mexico and Barbados
Claudia I. Juarez-Molina et al.
JOURNAL OF VIROLOGY (2014)
Phambili: moving forward without the blindfold
Nelson L. Michael et al.
LANCET INFECTIOUS DISEASES (2014)
Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
Nicola Borthwick et al.
MOLECULAR THERAPY (2014)
Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial
Emma-Jo Hayton et al.
PLOS ONE (2014)
HIV-1 Conserved Elements p24CE DNA Vaccine Induces Humoral Immune Responses with Broad Epitope Recognition in Macaques
Viraj Kulkarni et al.
PLOS ONE (2014)
Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence
Rebecca Payne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Alison L. Hill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design
Andrew L. Ferguson et al.
IMMUNITY (2013)
Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection
Holly Janes et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Immune clearance of highly pathogenic SIV infection
Scott G. Hansen et al.
NATURE (2013)
Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control
Srinika Ranasinghe et al.
NATURE MEDICINE (2013)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms
Scott G. Hansen et al.
SCIENCE (2013)
A Dendritic Cell-Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication
Felipe Garcia et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice
Beatrice Ondondo et al.
VACCINE (2013)
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Susanne Eriksson et al.
PLOS PATHOGENS (2013)
Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques
Maximillian Rosario et al.
AIDS (2012)
HIV and HLA Class I: An Evolving Relationship
Philip J. R. Goulder et al.
IMMUNITY (2012)
Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)
Ann Duerr et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Antiviral Inhibitory Capacity of CD8+ T cells Predicts the Rate of CD4+ T-Cell Decline in HIV-1 Infection
Hongbing Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine
Maria L. Knudsen et al.
JOURNAL OF VIROLOGY (2012)
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Matthew D. J. Dicks et al.
PLOS ONE (2012)
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Stefano Colloca et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
HIV-Specific Cytolytic CD4 T Cell Responses During Acute HIV Infection Predict Disease Outcome
Damien Z. Soghoian et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
Richard Hopkins et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Definition of the viral targets of protective HIV-1-specific T cell responses
Beatriz Mothe et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
HIV-1-Specific Interleukin-21(+) CD4(+) T Cell Responses Contribute to Durable Viral Control through the Modulation of HIV-Specific CD8(+) T Cell Function
Mathieu F. Chevalier et al.
JOURNAL OF VIROLOGY (2011)
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2h study
Glenda E. Gray et al.
LANCET INFECTIOUS DISEASES (2011)
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Scott G. Hansen et al.
NATURE (2011)
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
Morgane Rolland et al.
NATURE MEDICINE (2011)
Protective Efficacy of Serially Up-Ranked Subdominant CD8+ T Cell Epitopes against Virus Challenges
Eung-Jun Im et al.
PLOS PATHOGENS (2011)
Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques
Maximillian Rosario et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Prime-boost vectored malaria vaccines Progress and prospects
Adrian V. S. Hill et al.
HUMAN VACCINES (2010)
HIV Controllers with HLA-DRB1*13 and HLA-DQB1*06 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses
April L. Ferre et al.
JOURNAL OF VIROLOGY (2010)
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Florencia Pereyra et al.
SCIENCE (2010)
Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects
Sarah Howles et al.
VACCINE (2010)
Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine
Glenda Gray et al.
CURRENT OPINION IN HIV AND AIDS (2010)
Virological, immune and host genetics markers in the control of HIV infection
Beatriz Mothe et al.
DISEASE MARKERS (2009)
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
Nilu Goonetilleke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
Jesus F. Salazar-Gonzalez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Different Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope Specificity
Mitsuo Honda et al.
JOURNAL OF IMMUNOLOGY (2009)
Adenovirus Vector-Induced Immune Responses in Nonhuman Primates: Responses to Prime Boost Regimens
Nia Tatsis et al.
JOURNAL OF IMMUNOLOGY (2009)
T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces
Bette T. Korber et al.
JOURNAL OF VIROLOGY (2009)
Adaptation of HIV-1 to human leukocyte antigen class I
Yuka Kawashima et al.
NATURE (2009)
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
Scott G. Hansen et al.
NATURE MEDICINE (2009)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study
Cyril Dalmasso et al.
PLOS ONE (2008)
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
Sven Letourneau et al.
PLOS ONE (2007)
A whole-genome association study of major determinants for host control of HIV-1
Jacques Fellay et al.
SCIENCE (2007)
Evidence of differential HLA class I-Mediated viral evolution in functional and Accessory/Regulatory genes of HIV-1
Zabrina L. Brumme et al.
PLOS PATHOGENS (2007)
HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages
Mamoru Fujiwara et al.
BLOOD (2007)
Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes
Isobella Honeyborne et al.
JOURNAL OF VIROLOGY (2007)
Founder effects in the assessment of HIV polymorphisms and HLA allele associations
Tanmoy Bhattacharya et al.
SCIENCE (2007)
Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction
Tomas Hanke et al.
JOURNAL OF GENERAL VIROLOGY (2007)
CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load
Photini Kiepiela et al.
NATURE MEDICINE (2007)
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
Will Fischer et al.
NATURE MEDICINE (2007)
Hitting HIV where it hurts: an alternative approach to HIV vaccine design
Marcus Altfeld et al.
TRENDS IN IMMUNOLOGY (2006)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts et al.
NATURE (2006)
Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 gag coupled to CD8+ T-cell epitopes
Nilu Goonetilleke et al.
JOURNAL OF VIROLOGY (2006)
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1
J Martinez-Picado et al.
JOURNAL OF VIROLOGY (2006)
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
N Frahm et al.
NATURE IMMUNOLOGY (2006)
Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses
MJ Estcourt et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load
A Harari et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Will we be able to 'spot' an effective HIV-1 vaccine?
OO Yang
TRENDS IN IMMUNOLOGY (2003)
A simian replication-defective vaccine to HIV-1 gag
JC Fitzgerald et al.
JOURNAL OF IMMUNOLOGY (2003)
Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents
JM Tang et al.
AIDS (2002)
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
MB Pepys et al.
NATURE (2002)
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
V Appay et al.
NATURE MEDICINE (2002)
Evolution and transmission of stable CTL escape mutations in HIV infection
PJR Goulder et al.
NATURE (2001)